atopica 50 mg zachte caps.
elanco - ciclosporine 50 mg - capsule, zacht - 50 mg - ciclosporine 50 mg - ciclosporin - hond
atopica 25 mg zachte caps.
elanco - ciclosporine 25 mg - capsule, zacht - 25 mg - ciclosporine 25 mg - ciclosporin - hond
atopica 100 mg/ml or. opl.
elanco - ciclosporine 100 mg/ml - drank - 100 mg/ml - ciclosporine 100 mg/ml - ciclosporin - kat; hond
atopica 100 mg zachte capsules voor honden
elanco gmbh - ciclosporine - capsule, zacht - ciclosporine 100, - ciclosporin - honden
atopica 100 mg/ml orale oplossing voor katten en honden
elanco gmbh - ciclosporine - vloeistof voor oraal gebruik - ciclosporine 100 mg/ml, - ciclosporin - honden; katten
atopica 25 mg zachte capsules voor honden
elanco gmbh - ciclosporine - capsule, zacht - ciclosporine 25, - ciclosporin - honden
atopica 50 mg zachte capsules voor honden
elanco gmbh - ciclosporine - capsule, zacht - ciclosporine 50, - ciclosporin - honden
atopica 100 mg zachte caps.
elanco - ciclosporine 100 mg - capsule, zacht - 100 mg - ciclosporine 100 mg - ciclosporin - hond
protopic
leo pharma a/s - tacrolimus - dermatitis, atopic - andere dermatologische preparaten - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. voorkomende vier of meer keer per jaar) die last hebben gehad van een eerste reactie op een maximum van zes weken een behandeling van tweemaal daags tacrolimus zalf (laesies gewist, bijna gewist of licht aangetast).
adtralza
leo pharma a/s - tralokinumab - dermatitis, atopic - andere dermatologische preparaten - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.